Literature DB >> 25024794

Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus.

Ricardo A Rendon1, Anil Kapoor2, Rodney Breau3, Michael Leveridge4, Andrew Feifer5, Peter C Black6, Alan So6.   

Abstract

Entities:  

Year:  2014        PMID： 25024794      PMCID： PMC4081255          DOI： 10.5489/cuaj.1894

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  216 in total

1.  External validation of a nomogram using RENAL nephrometry score to predict high grade renal cell carcinoma.

Authors:  Hong-Kai Wang; Yao Zhu; Xu-Dong Yao; Shi-Lin Zhang; Bo Dai; Hai-Liang Zhang; Yi-Jun Shen; Chao-Fu Wang; Ding-Wei Ye
Journal:  J Urol       Date:  2012-03-14       Impact factor: 7.450

Review 2.  An update of the Bosniak renal cyst classification system.

Authors:  Gary M Israel; Morton A Bosniak
Journal:  Urology       Date:  2005-09       Impact factor: 2.649

3.  A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

Authors:  Bradley C Leibovich; John C Cheville; Christine M Lohse; Horst Zincke; Igor Frank; Eugene D Kwon; Jaime R Merchan; Michael L Blute
Journal:  J Urol       Date:  2005-11       Impact factor: 7.450

4.  Population based analysis of survival in patients with renal cell carcinoma and venous tumor thrombus.

Authors:  Jared M Whitson; Adam C Reese; Maxwell V Meng
Journal:  Urol Oncol       Date:  2011-07-27       Impact factor: 3.498

5.  Role of FDG PET-CT in recurrent renal cell carcinoma.

Authors:  Rakesh Kumar; Varun Shandal; Shamim Ahmed Shamim; Sunil Jeph; Harmandeep Singh; Arun Malhotra
Journal:  Nucl Med Commun       Date:  2010-10       Impact factor: 1.690

6.  The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses.

Authors:  Beverley A Shannon; Ronald J Cohen; Hildemarie de Bruto; Robert J Davies
Journal:  J Urol       Date:  2008-08-15       Impact factor: 7.450

7.  Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.

Authors:  Bradley C Leibovich; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Horst Zincke
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

8.  Adjuvant high-dose bolus interleukin-2 for patients with high-risk renal cell carcinoma: a cytokine working group randomized trial.

Authors:  Joseph I Clark; Michael B Atkins; Walter J Urba; Steven Creech; Robert A Figlin; Janice P Dutcher; Larry Flaherty; Jeffrey A Sosman; Theodore F Logan; Richard White; Geoffrey R Weiss; Bruce G Redman; Christopher P G Tretter; David McDermott; John W Smith; Michael S Gordon; Kim A Margolin
Journal:  J Clin Oncol       Date:  2003-06-16       Impact factor: 44.544

9.  Sunitinib efficacy against advanced renal cell carcinoma.

Authors:  Robert J Motzer; M Dror Michaelson; Jonathan Rosenberg; Ronald M Bukowski; Brendan D Curti; Daniel J George; Gary R Hudes; Bruce G Redman; Kim A Margolin; George Wilding
Journal:  J Urol       Date:  2007-09-17       Impact factor: 7.450

10.  Tumor complexity predicts malignant disease for small renal masses.

Authors:  Jeffrey K Mullins; Jihad H Kaouk; Sam Bhayani; Craig G Rogers; Michael D Stifelman; Phillip M Pierorazio; Youssef S Tanagho; Shahab P Hillyer; Bartosz F Kaczmarek; Yichun Chiu; Mohamad E Allaf
Journal:  J Urol       Date:  2012-10-18       Impact factor: 7.450
View more
  12 in total

1.  Canadian guidelines for the management of small renal masses (SRM).

Authors:  Michael A S Jewett; Ricardo Rendon; Louis Lacombe; Pierre I Karakiewicz; Simon Tanguay; Wassim Kassouf; Mike Leveridge; Ilias Cagiannos; Anil Kapoor; Stephen Pautler; Darrel Drachtenberg; Ronald Moore; Martin Gleave; Andrew Evans; Massoom Haider; Antonio Finelli
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

Review 2.  Transnasal Endoscopic Resection of the Intraconal Metastases From Renal Cell Carcinoma: a Case Report and Review of Literature.

Authors:  Ankit D Mahuvakar; Deepa Nair; Prathamesh S Pai
Journal:  Indian J Surg Oncol       Date:  2020-10-28

Review 3.  Stereotactic body radiotherapy for the treatment of medically inoperable primary renal cell carcinoma: Current evidence and future directions.

Authors:  Anand Swaminath; William Chu
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

4.  A case of renal cell carcinoma in a patient with situs inversus: Operative considerations and a review of the literature.

Authors:  Justin Oake; Darrel Drachenberg
Journal:  Can Urol Assoc J       Date:  2017-05-09       Impact factor: 1.862

5.  Surgical management of stage T1 renal tumours at Canadian academic centres.

Authors:  Luke T Lavallée; Simon Tanguay; Michael A Jewett; Lori Wood; Anil Kapoor; Ricardo A Rendon; Ronald B Moore; Louis Lacombe; Jun Kawakami; Stephen E Pautler; Darrel E Drachenberg; Peter C Black; Jean-Baptiste Lattouf; Christopher Morash; Ilias Cagiannos; Zhihui Liu; Rodney H Breau
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

6.  The prognostic effect of immunoscore in patients with clear cell renal cell carcinoma: preliminary results.

Authors:  Ismail Selvi; Umut Demirci; Nazan Bozdogan; Halil Basar
Journal:  Int Urol Nephrol       Date:  2019-09-20       Impact factor: 2.370

7.  Urinary volatile organic compounds as potential biomarkers for renal cell carcinoma.

Authors:  Dongchun Wang; Changsong Wang; Xin Pi; Lei Guo; Yue Wang; Mingjuan Li; Yue Feng; Ziwei Lin; Wei Hou; Enyou Li
Journal:  Biomed Rep       Date:  2016-05-20

8.  Platelet to white blood cell ratio predicts 30-day postoperative infectious complications in patients undergoing radical nephrectomy for renal malignancy.

Authors:  Alaina Garbens; Christopher J D Wallis; Georg Bjarnason; Girish S Kulkarni; Avery B Nathens; Robert K Nam; Raj Satkunasivam
Journal:  Can Urol Assoc J       Date:  2017-11       Impact factor: 1.862

9.  Survival Analysis of Pathological T3a Upstaging in Clinical T1 Renal Cell Carcinoma.

Authors:  Gu-Shun Lai; Jian-Ri Li; Shian-Shiang Wang; Chuan-Shu Chen; Chun-Kuang Yang; Sheng-Chun Hung; Chen-Li Cheng; Yen-Chuan Ou; Kun-Yuan Chiu
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

Review 10.  Indications for biopsy and the current status of focal therapy for renal tumours.

Authors:  Ricardo R N Leão; Patrick O Richard; Michael A S Jewett
Journal:  Transl Androl Urol       Date:  2015-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.